Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedCap ABOSTO:MCAP +2.87%80 OCF Margin % is 9.29% as of Mar. 2026, which is 27% below its 10-year median of 12.74. GuruFocus rates OSTO:MCAP with a GF Score™ of 80/100 and a GF Value™ of kr556.75 (Fairly Valued). Among 817 Medical Devices & Instruments companies, MedCap AB ranks better than 70.38% on this metric.
The historical rank and industry rank for MedCap AB's OCF Margin % or its related term are showing as below:
OSTO:MCAP'
s OCF Margin % Range Over the Past 10 Years
Min: -1.76 Med: 12.74 Max: 19.92
Current: 15.62
During the past 13 years, the highest OCF Margin % of MedCap AB was 19.92%. The lowest was -1.76%. And the median was 12.74%.
OSTO:MCAP's OCF Margin % is ranked better than 70.38% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs OSTO:MCAP: 15.62
MedCap AB OCF Margin % Related Terms
MedCap AB OCF Margin % Historical Data
* Premium members only.
The historical data trend for MedCap AB's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:MCAP vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, MedCap AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedCap AB OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's OCF Margin % distribution charts can be found below:
* The bar in red indicates where MedCap AB's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedCap AB (OSTO:MCAP) has a OCF Margin % of 9.29% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on MedCap AB and its competitors. This is 27% below median its historical median of 12.74. According to the industry distribution chart, MedCap AB ranks #242 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 29.6%.
Is MedCap AB's OCF Margin % too high?
MedCap AB's current OCF Margin % of 9.29% is 27% below median its 10-year median of 12.74. The Medical Devices & Instruments industry median OCF Margin % is 5.82. MedCap AB's value of 9.29% is 59.6% above this industry median. Based on the distribution chart, MedCap AB ranks #242 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, MedCap AB has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MedCap AB's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MedCap AB ranks #242 out of 817 companies for OCF Margin %. This puts MedCap AB in the upper half of its industry. The industry median OCF Margin % is 5.82. MedCap AB's value of 9.29% is 59.6% above this benchmark. While the company's 10-year median is 12.74 vs. the industry median of 5.82, MedCap AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedCap AB's current OCF Margin % of 9.29% is 59.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on MedCap AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedCap AB's current OCF Margin % is 9.29%, which is 27% below median its own 10-year median of 12.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedCap AB stock overvalued right now?
Based on GuruFocus' analysis, MedCap AB (OSTO:MCAP) is currently considered Fairly Valued. The stock's GF Value™ is kr556.75, compared to a current price of kr519.50 — trading 6.7% below its estimated fair value. The current OCF Margin % is 9.29%, which is 27% below median its 10-year median of 12.74 and 59.6% above the Medical Devices & Instruments industry median of 5.82. MedCap AB's overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For MedCap AB (OSTO:MCAP), the current OCF Margin % is 9.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedCap AB (OSTO:MCAP) Overvalued in 2026?
Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued.
The current stock price of kr519.50 is trading 6.7% below its estimated GF Value™ of kr556.75.
GuruFocus considers MedCap AB to be Fairly Valued.
Key valuation signals for OSTO:MCAP:
OCF Margin %: 9.29% (27% below median its 10-year median of 12.74)
GF Value™: kr556.75 vs. price of kr519.50 (6.7% below fair value)
Industry Position: 59.6% above the Medical Devices & Instruments median (#242 of 817)
No single metric tells the full story. See the OSTO:MCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
80GF Score
Get the complete analysis for OSTO:MCAP
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:MCAP has been successfully added to your 
